Just published: With the recent FDA-approval of #Xipere, clinicians are increasi…
[ad_1]
Just published: With the recent FDA-approval of #Xipere, clinicians are increasingly interested in Uveitic Macular Edema, the most common cause of vision loss in #uveitis.
OCT Biomarkers in Uveitic Macular Edema on @RetinaToday https://t.co/T0JqXtkqf9
[ad_2]
Source by Thomas Ciulla, MD, MBA